Skip to main content
Log in

Early continuous renal replacement therapy during infant extracorporeal life support is associated with decreased lung opacification

  • Original Article
  • Artificial Lung / ECMO
  • Published:
Journal of Artificial Organs Aims and scope Submit manuscript

Abstract

Lung opacification on chest radiography (CXR) is common during extracorporeal life support (ECLS), often resulting from pulmonary edema or inflammation. Concurrent use of continuous renal replacement therapy (CRRT) during ECLS is associated with improved fluid balance and cytokine filtration; through modification of these pathologic states, CRRT may modulate lung opacification observed on CXRs. We hypothesize that early CRRT use during infant ECLS decreases lung opacification on CXR. We conducted a retrospective cohort study comparing CXRs from infants receiving ECLS and early CRRT (n = 7) to matched infants who received ECLS alone (n = 7). The CXR obtained prior to ECLS, all CXRs obtained within the first 72 h of ECLS, and daily CXRs for the remainder of the ECLS course were analyzed. The outcome measure was the degree of opacification, determined by independent assessment of two, blinded pediatric radiologists using a modified Edwards et al.’s lung opacification scoring system (from Score 0: no opacification to Score 5: complete opacification). 220 CXRs were assessed (cases: 93, controls: 127). Inter-rater reliability was established (Cohen’s weighted к = 0.74; p < 0.0001, good agreement). At baseline, the mean opacification score difference between cases and controls was 1 point (cases: 1.8, controls 2.8; p = 0.049). Using mixed modeling analysis for repeated measures accounting for differences at baseline, the average overall opacification score was 1.2 points lower in cases than controls (cases: 2.1, controls: 3.3; p < 0.0001). The overall distribution of scores was lower in cases than controls. Early CRRT utilization during infant ECLS was associated with decreased lung opacification on CXR.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Barbaro R, et al. Pediatric extracorporeal life support organization registry International Report 2016. ASAIO J. 2017;63:456–63.

    Article  Google Scholar 

  2. Peek G, Firmin R. The inflammatory and coagulative response to prolonged extracorporeal membrane oxygenation. ASAIO J. 1999;45:250–63.

    Article  CAS  Google Scholar 

  3. Annich G et al. (2017) Adverse effects of extracorporeal life support: the blood biomaterial interaction in Extracorporeal Life Support: the ELSO Red Book. Brogan T et al. (ed). Extracorporeal Life Support Organization, Ann Arbor

  4. Selewski DT, et al. The impact of fluid overload on outcomes in children treated with extracorporeal membrane oxygenation: a multicenter retrospective cohort study. Pediatr Crit Care Med. 2017;18:1126.

    Article  Google Scholar 

  5. Jamadar D, et al. Extracorporeal membrane oxygenation in adults: radiographic findings and correlation of lung opacification and patient mortality. Radiology. 1996;198:693–8.

    Article  CAS  Google Scholar 

  6. Kelly RE Jr, et al. Pulmonary edema and fluid mobilization as determinants of the duration of ECMO support. J Pediatr Surg. 1991;26:1016–22.

    Article  Google Scholar 

  7. Taylor GA, et al. Diffuse pulmonary opacification in infants undergoing extracorporeal membrane oxygenation: clinical and pathologic correlation. Radiology. 1986;161:347–50.

    Article  CAS  Google Scholar 

  8. Blijdorp K, et al. Haemofiltration in newborns treated with extracorporeal membrane oxygenation: a case-comparison study. Crit Care. 2009;13:R48.

    Article  Google Scholar 

  9. Hoover N, et al. Enhanced fluid management with continuous venovenous hemofiltration in pediatric respiratory failure patients receiving extracorporeal membrane oxygenation support. Intensive Care Med. 2008;34:2241–7.

    Article  Google Scholar 

  10. Shen J, et al. Continuous renal replacement therapy (CRRT) attenuates myocardial inflammation and mitochondrial injury induced by venovenous extracorporeal membrane oxygenation (VV ECMO) in a healthy piglet model. Inflammation. 2013;36:1186–93.

    Article  CAS  Google Scholar 

  11. Morgera S, et al. Intermittent high permeability hemofiltration in septic patients with acute renal failure. Intensive Care Med. 2003;29:1989–95.

    Article  Google Scholar 

  12. Edwards DK, et al. Respiratory distress syndrome treated with human surfactant: radiographic findings. Radiology. 1985;157:329–34.

    Article  CAS  Google Scholar 

  13. Murphy HJ, et al. Implementing a practice change: early initiation of continuous renal replacement therapy during neonatal extracorporeal life support standardizes care and improves short-term outcomes. J Artif Organs. 2017;21:76–85.

    Article  Google Scholar 

  14. Askenazi DJ, et al. Acute kidney injury and renal replacement therapy independently predict mortality in neonatal and pediatric noncardiac patients on extracorporeal membrane oxygenation. Pediatr Crit Care Med. 2011;12:e1–6.

    Article  Google Scholar 

  15. Goldstein SL, et al. Outcome in children receiving continuous venovenous hemofiltration. Pediatrics. 2001;107:1309–12.

    Article  CAS  Google Scholar 

  16. Foland JA, et al. Fluid overload before continuous hemofiltration and survival in critically ill children: a retrospective analysis. Crit Care Med. 2004;32:1771–6.

    Article  Google Scholar 

  17. Sutherland SM, et al. Fluid overload and mortality in children receiving continuous renal replacement therapy: the prospective pediatric continuous renal replacement therapy registry. Am J Kidney Dis. 2010;55:316–25.

    Article  Google Scholar 

  18. Askenazi DJ, et al. Renal replacement therapy in critically ill patients receiving extracorporeal membrane oxygenation. Clin J Am Soc Nephrol. 2012;7:1328–36.

    Article  Google Scholar 

  19. Bellomo R, Tippping P, Boyce N. Interleukin-6 and interleukin-8 extraction during continuous venovenous hemodiafiltration in septic acute renal failure. Renal Failure. 1995;17:457–66.

    Article  CAS  Google Scholar 

  20. Mu TS, et al. Continuous renal replacement therapy to reduce inflammation in a piglet hemorrhage-reperfusion extracorporeal membrane oxygenation model. Pediatr Res. 2012;72:249–55.

    Article  CAS  Google Scholar 

  21. Murphy H, et al. Early continuous renal replacement therapy improves nutrition delivery in neonates during extracorporeal life support. J Ren Nutr. 2018;28:64–70.

    Article  Google Scholar 

  22. McILwain RB, et al. Plasma concentrations of inflammatory cytokines rise rapidly during ECMO-related SIRS due to the release of preformed stores in the intestine. Lab Invest. 2010;90:128–39.

    Article  CAS  Google Scholar 

  23. Zwiers AJ, et al. Acute kidney injury is a frequent complication in critically ill neonates receiving extracorporeal membrane oxygenation: a 14-year cohort study. Crit Care. 2013;17:R151.

    Article  Google Scholar 

  24. Selewski DT, et al. Fluid overload and fluid removal in pediatric patients on extracorporeal membrane oxygenation requiring continuous renal replacement therapy. Crit Care Med. 2012;40:2694–9.

    Article  CAS  Google Scholar 

  25. Wolf MJ, et al. Early renal replacement therapy during pediatric cardiac extracorporeal support increases mortality. Ann Thorac Surg. 2013;96:917–22.

    Article  Google Scholar 

  26. Arikan AA, et al. Fluid overload is associated with impaired oxygenation and morbidity in critically ill children. Pediatr Crit Care Med. 2012;13:253–8.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Heidi J. Murphy or David J. Annibale.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Murphy, H.J., Eklund, M.J., Hill, J. et al. Early continuous renal replacement therapy during infant extracorporeal life support is associated with decreased lung opacification. J Artif Organs 22, 286–293 (2019). https://doi.org/10.1007/s10047-019-01119-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10047-019-01119-1

Keywords

Navigation